UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$205M |
| 2 |
Johnson & Johnson
JNJ
|
+$186M |
| 3 |
Honeywell
HON
|
+$177M |
| 4 |
Mondelez International
MDLZ
|
+$132M |
| 5 |
Alibaba
BABA
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$270M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$212M |
| 3 |
Citigroup
C
|
+$185M |
| 4 |
Booking.com
BKNG
|
+$104M |
| 5 |
Intuitive Surgical
ISRG
|
+$103M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.89% |
| 2 | Technology | 14.47% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.06% |
| 5 | Communication Services | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$2.9T
| $1.87B | 2.11% |
36,468,268
-1,266,905
| -3% | -$65.8M |
|
2
Apple
AAPL
$4.79T
| $1.77B | 2% |
74,171,764
-3,054,724
| -4% | -$75.9M |
|
3
Meta Platforms (Facebook)
META
$1.59T
| $1.41B | 1.6% |
12,354,402
-700,513
| -5% | -$80.7M |
|
|
4
Johnson & Johnson
JNJ
$615B
| $1.37B | 1.54% |
11,255,956
+1,633,647
| +17% | +$186M |
|
5
Amazon
AMZN
$2.63T
| $1.31B | 1.48% |
36,607,960
-315,480
| -0.9% | -$10.7M |
|
6
Alphabet (Google) Class A
GOOGL
$4.17T
| $1.22B | 1.38% |
34,622,860
-66,060
| -0.2% | -$2.42M |
|
7
ExxonMobil
XOM
$640B
| $1.06B | 1.2% |
11,331,221
+243,426
| +2% | +$21.5M |
|
|
8
Alphabet (Google) Class C
GOOG
$4.17T
| $925M | 1.05% |
26,723,960
-595,840
| -2% | -$21.4M |
|
9
GE Aerospace
GE
$354B
| $916M | 1.04% |
6,072,193
-63,684
| -1% | -$9.29M |
|
10
PepsiCo
PEP
$185B
| $832M | 0.94% |
7,854,989
+480,168
| +7% | +$49.5M |
|
11
JPMorgan Chase
JPM
$926B
| $814M | 0.92% |
13,100,460
-68,246
| -0.5% | -$4.26M |
|
12
AT&T
T
$160B
| $757M | 0.86% |
23,205,798
+619,701
| +3% | +$18.4M |
|
13
Chevron
CVX
$384B
| $743M | 0.84% |
7,087,933
+29,865
| +0.4% | +$3M |
|
14
Home Depot
HD
$330B
| $741M | 0.84% |
5,803,315
-380,961
| -6% | -$50.4M |
|
15
Gilead Sciences
GILD
$162B
| $734M | 0.83% |
8,796,615
-217,946
| -2% | -$19.3M |
|
16
Wells Fargo
WFC
$262B
| $697M | 0.79% |
14,720,004
+315,549
| +2% | +$15.4M |
|
17
Visa
V
$672B
| $681M | 0.77% |
9,183,728
+586,165
| +7% | +$45.9M |
|
|
AGN
18
DELISTED
Allergan plc
AGN
| $661M | 0.75% |
2,860,816
-371,331
| -11% | -$85.6M |
|
19
Procter & Gamble
PG
$347B
| $657M | 0.74% |
7,761,242
+149,849
| +2% | +$12.3M |
|
20
UnitedHealth
UNH
$392B
| $647M | 0.73% |
4,584,200
+159,543
| +4% | +$21.3M |
|
21
Verizon
VZ
$185B
| $644M | 0.73% |
11,525,406
+401,182
| +4% | +$20.8M |
|
22
Amgen
AMGN
$198B
| $598M | 0.68% |
3,930,676
+218,029
| +6% | +$33.9M |
|
23
Berkshire Hathaway Class B
BRK.B
$1.06T
| $590M | 0.67% |
4,074,075
+396,229
| +11% | +$56.6M |
|
24
Pfizer
PFE
$141B
| $587M | 0.66% |
17,581,810
+1,672
| +0% | +$53.4K |
|
|
CELG
25
DELISTED
Celgene Corp
CELG
| $551M | 0.62% |
5,586,581
-26,251
| -0.5% | -$2.72M |
|
Similar funds
UBS AM's Q2 2016 Portfolio in Review
As of Q2 2016, UBS AM held 2,695 positions worth $88.5B, up 2.6% from $86.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2016 filing shows 65 new, 1,198 increased, 577 reduced and 89 closed positions. Its largest new stake was S&P Global: 1,914,020 shares worth $205M. The largest sale was MCGRAW-HILL FINANCIAL INC COM, an estimated $270M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q2 2016 buy was S&P Global: 1,914,020 shares worth $205M.
- UBS AM added most to Johnson & Johnson in Q2 2016, an estimated $186M increase.
- UBS AM's biggest Q2 2016 reduction was Citigroup, cutting an estimated $185M.
- UBS AM fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $270M.
- UBS AM's ten largest holdings make up 14% of its $88.5B portfolio in Q2 2016.
- UBS AM opened 65 new positions and closed 89 in Q2 2016.
- UBS AM's portfolio value rose 2.6% quarter-over-quarter to $88.5B.
Based on UBS AM's 13F filing for Q2 2016, filed 9 Aug 2016.